Pharma Journalist 9027 posts 0 comments

Silence Therapeutics plc a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with…
Read More...

Johnson & Johnson announced the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted 19-0 to recommend…
Read More...

Sutro Biopharma, Inc. a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create…
Read More...

GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced a new strategic collaboration with Labcorp, a leading global life…
Read More...

Immusoft, a cell therapy company dedicated to improving the lives of patients with rare diseases, announced that it has signed a research collaboration and license option agreement with…
Read More...

SMi Group reports: Chairman of the 4th Annual Ophthalmic Drugs conference has invited experts in the industry to join the discussion.  As Chair of the 4th Annual Ophthalmic Drugs…
Read More...

SMi Group reports: The 13th Annual RNA Therapeutics Conference is set to return in February 2022 with a key focus on the latest advances and opportunities in RNA-based medicine. SMi…
Read More...

SMi Group reports: SMi’s Medical Wearables for Biosensors virtual conference chair interview with Natalie Wisniewski, Medical Device Consultancy released. The inaugural virtual…
Read More...

Verus (EventMagix) and Online Seminar join forces to offer a virtual 'Future is Now' experience to partners in the healthcare industry. On Thursday, 28 October these virtual event…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced it will build a state-of-the-art mRNA facility in Africa with the goal of…
Read More...